Cutaneous T-cell lymphoma drug effective against Alzheimer's

A drug that has been approved for the treatment of cutaneous T-cell lymphoma (CTCL) for over ten years may provide the major treatment breakthrough in the fight against Alzheimer's disease.

The drug, bexarotene, is an oral drug approved for CTCL in patients who have received a previous therapy.

Researchers at Case Western University saw promise in bexarotene because of its mechanism of action: the drug is believed to boost expression of a protein called Apolipoprotein in the brain-- a protein that is chiefly responsible for clearing the brain of amyloid beta, the protein associated with the development of Alzheimer's by its build-up in the brain.

Using bexarotene in mice, researchers wrote in the journal Science that they were able to improve the cognitive abilities of mice with Alzheimer's and even reverse some of the disease's progressive effects.

The findings are being hailed as 'unprecedented' and could signal a potential treatment pathway in humans in the near future.

Source: Science

More Articles

More Articles

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

When you consider that the adult human body has anywhere from 300 to 700 lymph nodes, the better question might not be where ARE they located, but...

This entry looks at a non-Hodgkin's lymphoma called true histiocytic lymphoma (THL), also referred to as diffuse histiocytic lymphoma, and...

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Intravascular lymphoma is a subtype of 'Lymphoma', an umbrella term that loosely refers to several dozen...

While the average lifespan for hamsters is only about 2.5 years, and they are therefore less prone to long-term illnesses, it is possible for a...

Burkitt's lymphoma is an aggressive B-cell lymphoma that is common in children...

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

Lymphoma is a life-threatening disease, but is very treatable in most cases. The 5-year survival for patients diagnosed with non-Hodgkin's...

T cell lymphoma treatment options for these cancers are not especially effective and there is no absolute consensus about optimal treatments for...

Marginal zone lymphomas (MZL) are indolent lymphomas that affect the B-cells. The...

Lymphomas can arise from most any lymphatic tissue (lymph nodes, spleen, thymus, mucosa associated lymphoid...